GQG Partners LLC

Position in ABBV — AbbVie Inc.

CIK 1697233 FT. LAUDERDALE, FL

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$483,554,946

+$476,146,313 QoQ

Shares Held

1,921,614

+4033.7% QoQ

Ownership

0.109%

of shares outstanding

% of Portfolio

0.90%

of 13F equity value

Holder Rank

#84

of 4,150 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 93% Shared 0% None 7%

Healthcare · as of Jun 30, 2026

GQG Partners LLC holds $855,412,874 across 8 Drug Manufacturers - General names. ABBV ranks #1 (56.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	1,921,614	$483,554,946
2	NVS	Novartis AG	2,151,131	$337,125,250
3	AZN	Astrazeneca PLC	45,569	$8,640,793
4	MRK	Merck & Co., Inc.	53,092	$6,822,322
5	JNJ	Johnson & Johnson	25,158	$6,389,377
6	BMY	Bristol Myers Squibb Co	96,264	$5,546,731
7	SNY	Sanofi	97,640	$4,165,322
8	PFE	Pfizer Inc	131,567	$3,168,133

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$483,554,946	1,921,614	+4033.7%	Shares	Sole	2026-08-12
2023-03-31	$7,408,633	46,487	+5.7%	Shares	Sole	2023-05-12
2022-12-31	$7,107,607	43,980	-1.0%	Shares	Sole	2023-02-13
2022-09-30	$5,960,131	44,409	-98.5%	Shares	Sole	2022-11-14
2022-06-30	$467,386,119	3,051,620	+1706.1%	Shares	Sole	2022-08-15
2022-03-31	$27,390,916	168,965	+354.4%	Shares	Sole	2022-05-13
2021-12-31	$5,034,849	37,185	+214.4%	Shares	Sole	2022-02-14
2021-09-30	$1,275,778	11,827	+39.6%	Shares	Sole	2021-11-16
2021-06-30	$954,398	8,473	-99.7%	Shares	Sole	2021-08-13
2021-03-31	$337,026,191	3,114,269	-3.2%	Shares	Sole	2021-05-14
2020-12-31	$344,873,847	3,218,608	—	Shares	Sole	2021-02-12
No filing history on record for this holder in this stock.